COVID-19: ACT trials for colchicine and antithrombotic therapies

被引:2
|
作者
Barco, Stefano [1 ,2 ]
Schreiber, Karen [3 ,4 ,5 ]
机构
[1] Univ Hosp Zurich, Dept Angiol, CH-8091 Zurich, Switzerland
[2] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany
[3] Univ Southern Denmark, Danish Hosp Rheumat Dis, Sonderborg, Denmark
[4] Univ Southern Denmark, Dept Reg Hlth Res IRS, Odense, Denmark
[5] Guys & St Thomas NHS Fdn Trust, Thrombosis & Haemostasis, London, England
来源
LANCET RESPIRATORY MEDICINE | 2022年 / 10卷 / 12期
关键词
OPEN-LABEL; MULTICENTER; OUTPATIENTS;
D O I
10.1016/S2213-2600(22)00368-X
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1106 / 1108
页数:4
相关论文
共 50 条
  • [21] Pharmacogenomics of COVID-19 therapies
    Takuto Takahashi
    Jasmine A. Luzum
    Melanie R. Nicol
    Pamala A. Jacobson
    npj Genomic Medicine, 5
  • [22] Transcatheter Therapies For COVID-19
    Kipshidze, Nicholas
    White, Christopher
    Kipshidze, Nodar
    Reddy, Vivek
    Dangas, George
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B94 - B94
  • [23] Alternative therapies for Covid-19
    Sundararajan, G.
    Isaac, Prince J.
    Andal, V
    Lakshmipathy, R.
    MATERIALS TODAY-PROCEEDINGS, 2022, 55 : 327 - 329
  • [24] Immunomodulatory therapies for COVID-19
    Mathur, Poonam
    Kottilil, Shyamasundaran
    FRONTIERS IN MEDICINE, 2022, 9
  • [25] Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies
    Nix, Hayden P.
    Weijer, Charles
    BMC MEDICAL ETHICS, 2021, 22 (01)
  • [26] Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
    Vegivinti, Charan Thej Reddy
    Evanson, Kirk W.
    Lyons, Hannah
    Akosman, Izzet
    Barrett, Averi
    Hardy, Nicole
    Kane, Bernadette
    Keesari, Praneeth Reddy
    Pulakurthi, Yashwitha Sai
    Sheffels, Erin
    Balasubramanian, Prasanth
    Chibbar, Richa
    Chittajallu, Spandana
    Cowie, Kathryn
    Karon, J.
    Siegel, Lauren
    Tarchand, Ranita
    Zinn, Caleb
    Gupta, Nitin
    Kallmes, Kevin M.
    Saravu, Kavitha
    Touchette, Jillienne
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [27] Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials
    Abrams-Downey, Alexandra
    Saabiye, Joseph
    Vidaurrazaga, Monica
    EUROPEAN UROLOGY FOCUS, 2020, 6 (05): : 1028 - 1031
  • [28] Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies
    Hayden P. Nix
    Charles Weijer
    BMC Medical Ethics, 22
  • [29] Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
    Charan Thej Reddy Vegivinti
    Kirk W. Evanson
    Hannah Lyons
    Izzet Akosman
    Averi Barrett
    Nicole Hardy
    Bernadette Kane
    Praneeth Reddy Keesari
    Yashwitha Sai Pulakurthi
    Erin Sheffels
    Prasanth Balasubramanian
    Richa Chibbar
    Spandana Chittajallu
    Kathryn Cowie
    J. Karon
    Lauren Siegel
    Ranita Tarchand
    Caleb Zinn
    Nitin Gupta
    Kevin M. Kallmes
    Kavitha Saravu
    Jillienne Touchette
    BMC Infectious Diseases, 22
  • [30] Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
    Dijk, Stijntje W.
    Krijkamp, Eline M.
    Kunst, Natalia
    Gross, Cary P.
    Wong, John B.
    Hunink, M. G. Myriam
    VALUE IN HEALTH, 2022, 25 (08) : 1268 - 1280